These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 7884852)

  • 1. Peripheral blood mononuclear cells produce normal amounts of defective Vif- human immunodeficiency virus type 1 particles which are restricted for the preretrotranscription steps.
    Courcoul M; Patience C; Rey F; Blanc D; Harmache A; Sire J; Vigne R; Spire B
    J Virol; 1995 Apr; 69(4):2068-74. PubMed ID: 7884852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-free transmission of Vif mutants of HIV-1.
    Fan L; Peden K
    Virology; 1992 Sep; 190(1):19-29. PubMed ID: 1529528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immunodeficiency virus type 1 Vif- mutant particles from restrictive cells: role of Vif in correct particle assembly and infectivity.
    Borman AM; Quillent C; Charneau P; Dauguet C; Clavel F
    J Virol; 1995 Apr; 69(4):2058-67. PubMed ID: 7884851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. vif-negative human immunodeficiency virus type 1 persistently replicates in primary macrophages, producing attenuated progeny virus.
    Chowdhury IH; Chao W; Potash MJ; Sova P; Gendelman HE; Volsky DJ
    J Virol; 1996 Aug; 70(8):5336-45. PubMed ID: 8764044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. gag, vif, and nef genes contribute to the homologous viral interference induced by a nonproducer human immunodeficiency virus type 1 (HIV-1) variant: identification of novel HIV-1-inhibiting viral protein mutants.
    D'Aloja P; Olivetta E; Bona R; Nappi F; Pedacchia D; Pugliese K; Ferrari G; Verani P; Federico M
    J Virol; 1998 May; 72(5):4308-19. PubMed ID: 9557721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures.
    Liu H; Wu X; Newman M; Shaw GM; Hahn BH; Kappes JC
    J Virol; 1995 Dec; 69(12):7630-8. PubMed ID: 7494271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypically Vif- human immunodeficiency virus type 1 is produced by chronically infected restrictive cells.
    Bouyac M; Rey F; Nascimbeni M; Courcoul M; Sire J; Blanc D; Clavel F; Vigne R; Spire B
    J Virol; 1997 Mar; 71(3):2473-7. PubMed ID: 9032385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of vif mutations on cell-free infectivity and replication of simian immunodeficiency virus.
    Park IW; Myrick K; Sodroski J
    J Acquir Immune Defic Syndr (1988); 1994 Dec; 7(12):1228-36. PubMed ID: 7965633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of human immunodeficiency virus type 1 Vif particle incorporation.
    Camaur D; Trono D
    J Virol; 1996 Sep; 70(9):6106-11. PubMed ID: 8709234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial rescue of the Vif-negative phenotype of mutant human immunodeficiency virus type 1 strains from nonpermissive cells by intravirion reverse transcription.
    Dornadula G; Yang S; Pomerantz RJ; Zhang H
    J Virol; 2000 Mar; 74(6):2594-602. PubMed ID: 10684273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-free HIV-1Zr6 vif mutants are defective in binding to peripheral blood mononuclear cells and in internalization.
    Nagashunmugam T; Friedman HM
    DNA Cell Biol; 1996 May; 15(5):353-61. PubMed ID: 8924209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional neutralization of HIV-1 Vif protein by intracellular immunization inhibits reverse transcription and viral replication.
    Goncalves J; Silva F; Freitas-Vieira A; Santa-Marta M; Malhó R; Yang X; Gabuzda D; Barbas C
    J Biol Chem; 2002 Aug; 277(35):32036-45. PubMed ID: 12039955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The replicative impairment of Vif- mutants of human immunodeficiency virus type 1 correlates with an overall defect in viral DNA synthesis.
    Nascimbeni M; Bouyac M; Rey F; Spire B; Clavel F
    J Gen Virol; 1998 Aug; 79 ( Pt 8)():1945-50. PubMed ID: 9714242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes.
    Gabuzda DH; Lawrence K; Langhoff E; Terwilliger E; Dorfman T; Haseltine WA; Sodroski J
    J Virol; 1992 Nov; 66(11):6489-95. PubMed ID: 1357189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged infection of peripheral blood lymphocytes by Vif-negative HIV type 1 induces resistance to productive HIV type 1 infection through soluble factors.
    Simm M; Pekarskaya O; Potash MJ; Volsky DJ
    AIDS Res Hum Retroviruses; 2000 Jul; 16(10):943-52. PubMed ID: 10890355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by a two-amino-acid insertion in HIV-1 Vif from a nonprogressing mother and child.
    Alexander L; Aquino-DeJesus MJ; Chan M; Andiman WA
    J Virol; 2002 Oct; 76(20):10533-9. PubMed ID: 12239333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complementation of human immunodeficiency virus type 1 vif mutants in some CD4+ T-cell lines.
    Hevey M; Donehower LA
    Virus Res; 1994 Sep; 33(3):269-80. PubMed ID: 7527173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of human immunodeficiency virus type 1 Vif with RNA and its role in reverse transcription.
    Dettenhofer M; Cen S; Carlson BA; Kleiman L; Yu XF
    J Virol; 2000 Oct; 74(19):8938-45. PubMed ID: 10982337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human immunodeficiency virus type 1 Vif is efficiently packaged into virions during productive but not chronic infection.
    Kao S; Akari H; Khan MA; Dettenhofer M; Yu XF; Strebel K
    J Virol; 2003 Jan; 77(2):1131-40. PubMed ID: 12502829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ring finger protein ZIN interacts with human immunodeficiency virus type 1 Vif.
    Feng F; Davis A; Lake JA; Carr J; Xia W; Burrell C; Li P
    J Virol; 2004 Oct; 78(19):10574-81. PubMed ID: 15367624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.